UVEAL MELANOMA, METASTATIC

Clinical trials for UVEAL MELANOMA, METASTATIC explained in plain language.

Never miss a new study

Get alerted when new UVEAL MELANOMA, METASTATIC trials appear

Sign up with your email to follow new studies for UVEAL MELANOMA, METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

New combo therapy targets liver tumors in rare eye cancer

Disease control Ongoing

This study tests a combination of two immunotherapy drugs (ipilimumab and nivolumab) plus a chemotherapy drug (melphalan) given directly to the liver for people with advanced uveal melanoma that has spread, especially to the liver. The goal is to see if this approach is safe and …

Matched conditions: UVEAL MELANOMA, METASTATIC

Phase: PHASE1, PHASE2 • Sponsor: Leiden University Medical Center • Aim: Disease control

Last updated Apr 30, 2026 15:51 UTC

UVEAL MELANOMA, METASTATIC

Get alerted when new UVEAL MELANOMA, METASTATIC trials appear

New combo therapy targets liver tumors in rare eye cancer